Medical registration fee dropped from 90,000 to 0 yuan

As of May 1, 2019, the registration fee standard for drugs and medical devices in Beijing has been reduced to zero. Not only that, but also the fees collected in advance should be refunded to the payer. On April 26, the official website of the Beijing Development and Reform Commission issued a notice of the Beijing Municipal Finance Bureau of the Beijing Municipal Development and Reform Commission on reducing the registration fee standard for pharmaceutical and medical devices products in the city. It said that the registration fee standard for pharmaceutical and medical devices products in Beijing had been reduced to zero since May 1, 1919. The documents emphasize the situation of arrears of payment. The above-mentioned administrative and business income that was arrears in previous years should continue to be collected and handed over to the state treasury in full. After the completion of the recovery work, enterprises should go through the formalities of paying bills in time to the financial department. The above administrative fees collected in advance will be refunded to the contributor. According to the Beijing News, the reason why Beijing Development and Reform Commission changed its registration fee is that in order to implement the policy spirit of reducing taxes and fees, it responded positively to the opinions and suggestions of some deputies to the National People's Congress of the 2019 Municipal People's Congress and further optimized the business environment of the city. It is expected that after the change of registration fee, the burden of enterprises will be reduced by about 66 million yuan this year. Relevant leaders of the Municipal Drug Regulatory Bureau said that the implementation of the fee reduction policy would be conducive to promoting the innovation and development of pharmaceutical enterprises, promoting more high-end innovative achievements to land, and speeding up the transformation and upgrading of Beijing's pharmaceutical health industry. After the promulgation of the new standard, registration fee dropped from 90,000 to 0 yuan.

The Beijing Development and Reform Commission and the Beijing Municipal Finance Bureau previously issued the Letter on the Standard of Registration Fees for Pharmaceutical and Medical Devices Products and the Notice on Cleaning up Policies Related to Regulate a Batch of Administrative Charges for Pharmaceutical and Medical Devices Products. Standard provisions shall be repealed at the same time. The abolished documents show that the original medical equipment registration fee standard has been implemented since July 1, 2017. The first registration fee is 93900 yuan and the change registration fee is 39300 yuan, which is the provincial unit with the highest national fee standard before.

This registration fee is exempted directly, which shows that the intensity of reduction is great. Except for Beijing, the provincial units exempt from registration fees are Tianjin and Hubei. In addition, the new standard was issued in April in Hunan Province, which also declined by more than 20,000 yuan for the first registration fee of each variety, and nearly 10,000 yuan for the change of registration fee and the continuation of registration fee.Cyberblue Instruments has compiled the latest edition of 24 provincial units'second-class registration fee standard table for readers to consult. From the statistics of the national situation, 24 provinces/municipalities/autonomous regions have published the second-class fee standard so far, 14 regions have reduced the registration fee, and the reduction range is larger, with individual provinces down more than 100%.

Medical device product registration fee is a national administrative matter related to enterprises. Professional fee items are the fees charged to applicants when applying for registration of pharmaceutical and medical devices products. At present, the registration of drugs and medical devices is managed at different levels. The provincial drug regulatory authorities are responsible for the examination and approval of the domestic drugs, including the supplementary application registration without changing the internal quality, the re-registration after the expiration of five years, the first registration and change registration of the second category of medical devices in China, and the renewal registration after the expiration of five years. In the formulation of charging standards for products registered by provincial drug regulatory departments, the charging standards shall be formulated by provincial price management departments in conjunction with financial departments.